At a glance
ClinicalIndex Comparison RecordN/ACompleted· 122 enrolled
Drug / intervention
AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PEdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
In Brief
A clinical study evaluating AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Pulmonary Embolism and Acute Pulmonary Embolism. Completed, enrolled 122 participants across 25 sites.
Detailed Summary
To evaluate the safety and effectiveness of percutaneous mechanical aspiration thrombectomy using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE in a prospective trial of patients with acute intermediate-risk pulmonary embolism (PE).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Embolism, Acute Pulmonary Embolism
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedApr 2022
Enrollment StartOct 2022
Primary CompletionJan 2024
TodayJul 2026
First PostedApr 8, 2022
Enrollment StartOct 19, 2022
Primary CompletionJan 4, 2024
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 4.2 years ago
Interventions
AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PEdevice
The AngioDynamics' AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE has five main components, a flexible cannula (F1885), sheath, tapered obturator, aspirator handle, and waste bag.